Belite Bio, Inc (BLTE)
NASDAQ: BLTE · IEX Real-Time Price · USD
34.48
+1.05 (3.14%)
Apr 22, 2024, 4:30 PM EDT - Market closed
Belite Bio Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Belite Bio stock have an average target of 48.8, with a low estimate of 25 and a high estimate of 60. The average target predicts an increase of 41.53% from the current stock price of 34.48.
Analyst Consensus: Strong Buy
* Price targets were last updated on Mar 22, 2024.
Analyst Ratings
The average analyst rating for Belite Bio stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $59 | Strong Buy | Maintains | $59 | +71.11% | Mar 22, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +71.11% | Mar 13, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +71.11% | Dec 27, 2023 |
| Maxim Group | Maxim Group | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +74.01% | Dec 14, 2023 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $59 | Strong Buy | Reiterates | $59 | +71.11% | Nov 15, 2023 |
Financial Forecast
Revenue This Year
12.75M
Revenue Next Year
8.50M
from 12.75M
Decreased by -33.33%
EPS This Year
-0.78
from -1.19
EPS Next Year
-0.84
from -0.78
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 52.5M | 26.3M | 76.0M | 99.0M | 224.3M |
| Avg | 12.8M | 8.5M | 34.8M | 96.1M | 217.9M |
| Low | n/a | n/a | n/a | 92.3M | 209.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | 105.9% | 794.4% | 184.4% | 133.3% |
| Avg | - | -33.3% | 309.6% | 176.1% | 126.6% |
| Low | - | - | - | 165.2% | 117.7% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 0.11 | -0.84 | 0.05 | 0.62 | 2.67 |
| Avg | -0.78 | -0.84 | -0.59 | 0.38 | 2.59 |
| Low | -1.08 | -0.84 | -1.45 | 0.15 | 2.49 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 606.7% |
| Avg | - | - | - | - | 586.5% |
| Low | - | - | - | - | 559.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.